| 5282 |
Centers for Disease Control and Prevention |
Html |
en |
2009 H1N1 Influenza Vaccine with Long-Dated Expiration Questions and Answers |
null |
| PHER funds | 0.30649 |
| long-expiry vaccine | 0.477663 |
| CDC | 0.244278 |
| seasonal vaccine | 0.739377 |
| trivalent influenza vaccine | 0.606499 |
| H1N1monovalent vaccine | 0.468427 |
| expired vaccine | 0.465777 |
| Recovery Program | 0.267109 |
| seasonal vaccine distribution | 0.525838 |
| influenza vaccine expiration | 0.599702 |
| H1N1 influenza activity | 0.353056 |
| cold chain integrity | 0.302372 |
| seasonal trivalent influenza | 0.375668 |
| state health departments | 0.298715 |
| influenza vaccine | 0.692965 |
| PM EDT | 0.273092 |
| early fall | 0.257868 |
| sufficient supply | 0.255604 |
| vaccination increase | 0.254759 |
| refrigerator storage | 0.256652 |
| Pasteur multi-dose vials | 0.327095 |
| direct communication | 0.25253 |
| H1N1 strain | 0.316858 |
| healthcare providers | 0.256888 |
| H1N1 vaccine supplies | 0.507032 |
|
| flu vaccine | 0.447523 |
| H1N1 Central Vaccine | 0.570231 |
| Sanofi Pasteur MDV | 0.335938 |
| robust supply | 0.252623 |
| H1N1 disease | 0.262761 |
| influenza A strain | 0.299158 |
| seasonal influenza vaccine | 0.681852 |
| trivalent vaccine | 0.571325 |
| event | 0.22955 |
| health care providers | 0.298075 |
| grantees | 0.240746 |
| high risk conditions | 0.297871 |
| resurgence | 0.242395 |
| seasonal  trivalent vaccine | 0.546047 |
| vaccine viability | 0.461118 |
| Sanofi Pasteur | 0.343634 |
| assured. States | 0.255477 |
| provider temperature logs | 0.299696 |
| vaccine | 0.922234 |
| 2010-11 seasonal vaccine | 0.554757 |
| 2010-2011 seasonal vaccine | 0.548774 |
| expiration dates | 0.322562 |
| viable vaccine | 0.466227 |
| time | 0.219489 |
|
CLICK HERE |
| 6981 |
Centers for Disease Control and Prevention |
Html |
en |
Global Health - Mozambique |
null |
| strategic information | 0.512 |
| CDC | 0.978435 |
| endorsement | 0.282863 |
| access | 0.251364 |
| medical male circumcisions | 0.781724 |
| public health policies | 0.82987 |
| HIV/AIDS counseling | 0.560444 |
| antiretroviral treatment | 0.603272 |
| Content source | 0.489658 |
| HHS | 0.289441 |
| FY | 0.407604 |
| Mozambique | 0.400901 |
| transmission | 0.24737 |
| Notice | 0.257785 |
| children | 0.248855 |
| lab infrastructure | 0.521257 |
| Download Overview Fact | 0.765025 |
|
| CDC initiatives | 0.900676 |
| health systems | 0.504392 |
| HIV/AIDS care | 0.543303 |
| infants | 0.260379 |
| work | 0.252884 |
| testing | 0.252607 |
| HIV-positive pregnant women | 0.781042 |
| prevention programs | 0.512848 |
| TB/HIV care | 0.580332 |
| services | 0.256589 |
| improvement | 0.255483 |
| capacity development | 0.553043 |
| non-federal site | 0.533329 |
| partners | 0.257069 |
| provision | 0.332126 |
| blood safety | 0.521078 |
| antiretroviral drugs | 0.602311 |
|
CLICK HERE |
| 7523 |
Centers for Disease Control and Prevention |
Html |
en |
Perchlorate in Baby Formula Fact Sheet-National Center for Environmental Health |
Data Resources for the National Center for Environmental Health |
| formula product | 0.448217 |
| conservative hypothetical exposure | 0.465598 |
| CDC | 0.543163 |
| available powdered infant | 0.478062 |
| thyroid hormone | 0.434146 |
| potential health effects | 0.767045 |
| perchlorate exposure | 0.741019 |
| synthetic amino acids | 0.431525 |
| reference dose | 0.508536 |
| fact sheet | 0.450996 |
| powdered infant formulas | 0.605372 |
| S. Environmental Protection | 0.556572 |
| mixed formula | 0.449552 |
| low levels | 0.437077 |
| soy-based formulas | 0.389025 |
| Previous CDC studies | 0.486554 |
| perchlorate | 0.958296 |
| hypothetical dosing situations | 0.445302 |
| infants | 0.505193 |
| infant formula | 0.630751 |
| lower risk | 0.42154 |
| diverse set | 0.431998 |
| significantly higher concentration | 0.427021 |
| recent study | 0.394279 |
| various chronic diseases | 0.423837 |
|
| hypothetical situation | 0.389469 |
| Environmental Protection Agency | 0.560469 |
| milk-based formulas | 0.395832 |
| U. S. Food | 0.4198 |
| study | 0.483755 |
| hypothetical exposure scenarios | 0.578715 |
| small study | 0.428884 |
| best feed infants | 0.489907 |
| thyroid gland | 0.437323 |
| Environmental Epidemiology1 | 0.382209 |
| formula products | 0.502028 |
| small numbers | 0.433035 |
| hypothetical exposure situations | 0.479487 |
| elemental formulas | 0.386011 |
| breast milk | 0.440547 |
| CDC researchers | 0.419094 |
| fact sheet answers | 0.449726 |
| Exposure Science | 0.418245 |
| U. S. Environmental | 0.552675 |
| infant feeding | 0.585061 |
| milk-based formula | 0.457029 |
| ill effects | 0.42411 |
| formula | 0.718527 |
| daily exposure levels | 0.468371 |
|
CLICK HERE |
| 8276 |
Centers for Disease Control and Prevention |
Html |
en |
Preventing Chronic Disease | Recruitment and RetentionTechniques for Developing Faith-Based Research Partnerships, NewYork City, 2009-2012 - CDC |
Faith-based organizations are recognized as an influential venue for behavioral health interventions. However, less is known about efficient approaches for identifying and recruiting these organizations and about the processes that enable successful partnership. |
| FBO member | 0.696009 |
| larger FBO | 0.683734 |
| partnering FBO | 0.699932 |
| New York City | 0.66759 |
| Project SCALE | 0.661517 |
| South Bronx | 0.644593 |
| FBO | 0.927513 |
| FBO leadership | 0.716625 |
| behavioral health intervention | 0.633112 |
| study informational request | 0.626808 |
| 12-week pilot study | 0.633576 |
| study participation | 0.663135 |
| study materials | 0.635125 |
| Community United Methodist | 0.629534 |
| behavioral health interventions | 0.675876 |
| FBO’s leaders | 0.707489 |
| extra FBO activities | 0.752127 |
| external FBO activities | 0.751704 |
| physical activity strategies | 0.635721 |
| study recruitment | 0.654803 |
| intervention | 0.721308 |
| Abyssinian Baptist Church | 0.626714 |
| FBO leaders | 0.751507 |
| study | 0.927376 |
|
| FBO events | 0.681507 |
| spiritual leaders | 0.62952 |
| FBO members | 0.715345 |
| weight loss intervention | 0.638304 |
| FBO sites | 0.712871 |
| FBO’s infrastructure | 0.700379 |
| FBO’s membership | 0.684972 |
| faith-based organizations | 0.75875 |
| smaller FBO | 0.685775 |
| group orientation sessions | 0.654028 |
| community-based participatory research | 0.631825 |
| study planning meetings | 0.632666 |
| FBOs | 0.734429 |
| New York | 0.715119 |
| Cornell Medical College | 0.746393 |
| FBO activities | 0.760446 |
| Mental Health Center | 0.663463 |
| physical activity | 0.801143 |
| FBO membership | 0.699486 |
| study personnel | 0.68053 |
| United Methodist Church | 0.628502 |
| Metropolitan Community United | 0.629539 |
| Weill Cornell Medical | 0.694609 |
| study staff | 0.753657 |
|
CLICK HERE |
| 9325 |
Centers for Disease Control and Prevention |
Html |
es |
Intervenciones en tiendas de alimentos pequeñas para cambiar el entorno alimentario, mejorar los hábitos alimenticios y reducir el riesgo de enfermedades crónicas |
CDC - Wide Page example description goes here |
| food environment | 0.591096 |
| hábitos alimenticios | 0.948151 |
| small food stores | 0.744706 |
| Rowan M | 0.568939 |
|
| siguientes criterios | 0.561925 |
| Gittelsohn J | 0.554751 |
| Gadhoke P | 0.55854 |
| Estados Unidos | 0.729921 |
|
CLICK HERE |
| 10706 |
Centers for Disease Control and Prevention |
Html |
en |
Short and Extended Messages'Viral Hemorrhagic Fevers - VHF' Communicating in the First Hours |
The CERC training program educates people on the principles and application of crisis and emergency risk communication when responding to a public health emergency. |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 11113 |
Centers for Disease Control and Prevention |
Html |
en |
2008 National Report on Biochemical Indicators of Diet and Nutrition - Table 4.1 |
null |
| Estimate | 0.263867 |
| Total population | 0.303364 |
| urine concentrations | 0.567388 |
| Males | 0.431576 |
| Search Form Controls | 0.312863 |
| conf. interval | 0.88306 |
| creatinine | 0.325195 |
| Urinary equol | 0.258666 |
| file | 0.291111 |
| Geometric mean | 0.876941 |
| small cell size | 0.589609 |
| Urinary enterolactone | 0.258587 |
| Urinary O-desmethylangolensin | 0.258639 |
| Serum | 0.309554 |
| u.s. population | 0.587991 |
| Nutrition Examination Survey | 0.81028 |
| μg/g creatinine | 0.323763 |
| Biochemical Indicators | 0.263975 |
| National Report | 0.257026 |
| Tweet Share Compartir | 0.265254 |
| Urinary enterodiol | 0.258613 |
|
| greater uncertainty | 0.438278 |
| percentiles | 0.419781 |
| Mexican Americans | 0.404256 |
| Table | 0.447962 |
| non-hispanic whites | 0.392422 |
| Iodine Urinary iodine | 0.271037 |
| Urinary iodine | 0.986574 |
| Lignans Urinary genistein | 0.259871 |
| Fat-Soluble Vitamins | 0.251955 |
| Sample | 0.309185 |
| page options Skip | 0.260275 |
| Search Controls | 0.259881 |
| non-hispanic blacks | 0.397389 |
| total U.S. population | 0.30047 |
| National Health | 0.551723 |
| Urinary daidzein | 0.258692 |
| Compounds Serum folate | 0.252925 |
| Trace Elements | 0.254438 |
| Serum transferrin saturation | 0.254495 |
| Home Executive Summary | 0.25299 |
| page | 0.370529 |
|
CLICK HERE |
| 11129 |
Centers for Disease Control and Prevention |
Html |
en |
B Virus 'Specimen Collection and Detection | Herpes B | CDC |
In cases of B virus exposure and infection, specimens for virus culture and serologic testing should be obtained from the exposed person and, when feasible, from the source animal. |
| rapid diagnosis | 0.385188 |
| Antiviral research | 0.393454 |
| virus Resource Center | 0.980816 |
| viable B virus | 0.587739 |
| virus exposure | 0.670905 |
| virus serologic methods | 0.656347 |
| educational resources | 0.391635 |
| possible exposures | 0.388567 |
| PCR protocols | 0.409221 |
| treatment monitoring | 0.38923 |
| diagnostic laboratories | 0.395955 |
| therapy decisions | 0.379056 |
| real-time PCR method | 0.482871 |
| zoonotic infections | 0.404824 |
| diagnostic testing | 0.402248 |
| appropriate caution | 0.381632 |
| research laboratories | 0.387214 |
| HSV | 0.374129 |
| biosafety level | 0.386522 |
| up-to-date strategies | 0.388157 |
| zoonotically infected humans | 0.463563 |
| additional advantage | 0.377258 |
| wound area | 0.394417 |
| emergency information | 0.391552 |
| diagnostic methods | 0.390577 |
|
| National B virus | 0.776009 |
| herpes simplex virus | 0.678025 |
| cleansing protocol | 0.388933 |
| virus detection | 0.596585 |
| possible exposure event | 0.464416 |
| source animal | 0.398559 |
| direct detection | 0.378358 |
| PCR testing | 0.425627 |
| containment facility | 0.382191 |
| hazardous procedure | 0.375333 |
| Georgia State University | 0.478875 |
| Viral Immunology Center | 0.482395 |
| serologic testing | 0.400892 |
| current drug sensitivities | 0.468554 |
| sample collection | 0.397792 |
| PCR diagnostic assay | 0.488765 |
| specimens | 0.333544 |
| virus culture | 0.649989 |
| virus infection | 0.646484 |
| essential first step | 0.381281 |
| substantial levels | 0.385147 |
| natural host | 0.39015 |
| Direct culture | 0.381404 |
| diagnostic laboratory workers | 0.453594 |
|
CLICK HERE |
| 13168 |
Centers for Disease Control and Prevention |
Html |
en |
April is Alcohol Awareness Month | CDC Features |
By not drinking too much, you can reduce the risk of short- and long-term health risks. |
| alcohol availability | 0.570068 |
| underage drinking | 0.515653 |
| screening | 0.334239 |
| instance | 0.321072 |
| binge drinkers | 0.462186 |
| effective community | 0.404842 |
| binge drinking | 0.540041 |
| high-quality treatment | 0.400311 |
| comprehensive approach | 0.406532 |
| deaths | 0.384739 |
| alcohol | 0.983199 |
| inability | 0.324347 |
| liver disease | 0.519881 |
| lives | 0.320686 |
| alcohol poisoning | 0.589484 |
| health problems | 0.415532 |
| Chronic Disease | 0.510436 |
| health effects | 0.486494 |
| high-quality substance abuse | 0.490283 |
| study | 0.394208 |
| past history | 0.411517 |
| related harms | 0.408437 |
| potential life | 0.416988 |
| adults | 0.401287 |
| excessive drinking−such | 0.529827 |
|
| alcohol dependence increase | 0.681666 |
| excessive alcohol | 0.929154 |
| alcohol dependence | 0.874156 |
| excessive drinkers | 0.653131 |
| adult drinkers | 0.452661 |
| heart disease | 0.413602 |
| strong craving | 0.413941 |
| evidence-based community strategies | 0.486851 |
| excessive drinking | 0.846404 |
| long-term health risks | 0.529894 |
| medical problem | 0.40134 |
| short period | 0.407341 |
| violence | 0.343884 |
| chronic medical condition | 0.497154 |
| clinical prevention strategies | 0.493757 |
| CDC researchers | 0.423948 |
| breast cancer | 0.407946 |
| people | 0.340201 |
| multiple occasions | 0.40749 |
| primary care | 0.407422 |
| healthcare settings | 0.403844 |
| motor vehicle crashes | 0.509854 |
| greatest impact | 0.403093 |
| time | 0.337042 |
|
CLICK HERE |
| 14059 |
Centers for Disease Control and Prevention |
Html |
es |
Enfermedad inflamatoria pélvica - Hoja informativa de los CDC |
Enfermedad inflamatoria pélvica: Hoja informativa de los CDC |
| Archivo Apple Quicktime | 0.789574 |
| pequeño aumento | 0.69808 |
| largo plazo | 0.693992 |
| Archivo RealPlayer | 0.684919 |
| Archivo Zip Comprimido | 0.784946 |
|
| Archivo Microsoft PowerPoint | 0.815824 |
| Archivo Adobe PDF | 0.789697 |
| Archivo Microsoft Excel | 0.788407 |
| Archivo Microsoft | 0.998714 |
| usa condones | 0.713153 |
|
CLICK HERE |